AKT1 and cancer: The current state of research postulates that PIK3CA-mutation-dependent activation of AKT phosphorylates and activates ER leading to transcriptional activity of ER in an oestradiol-independent manner and consecutively to preferential growth of ER-positive cancer [22, 23].